| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 3 1280-1286, Copyright © 1995 by American Association of Immunologists
ARTICLES |
S Beissert, J Hosoi, S Grabbe, A Asahina and RD Granstein
Massachusetts General Hospital/Harvard Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital-East and Harvard Medical School, Charlestown 02129.
IL-10 inhibits Langerhans cell (LC) Ag presentation to Th1 clones. As LC are capable of presenting tumor-associated Ags (TAA) for primary and secondary tumor immune responses, we examined the effect of IL-10 on LC Ag presentation in a model of immunity to the S1509a spindle cell tumor (H-2a). Because induction of immunity to S1509a requires exposure of LC to granulocyte-macrophage (GM)-CSF, this system also allowed us to study the regulatory interactions of GM-CSF and IL-10 on LC. Naive CAF1 (H-2a/d) mice could be immunized against S1509a by injection with GM- CSF-exposed and TAA-pulsed epidermal cells (EC) as assessed by inhibition of the growth of inoculated tumor cells. Incubation of EC in IL-10 before GM-CSF exposure completely inhibited Ag presentation in this system. Significantly, neither co-incubation of EC in IL-10 and GM- CSF (without preincubation in IL-10) nor IL-10 treatment after GM-CSF incubation was able to exert a down-regulatory effect. The ability of IL-10 to modulate EC presentation of TAA for a secondary immune response was also examined. EC were pulsed with TAA in vitro and then injected into a hind footpad of tumor-immune mice with 24 h swelling assessed as a measure of delayed-type hypersensitivity. Preincubation in IL-10 before TAA exposure significantly inhibited elicitation of delayed-type hypersensitivity with or without subsequent exposure to GM- CSF. Co-incubation of EC in IL-10 and GM-CSF or exposure to IL-10 after GM-CSF led to a normal response. These data indicate that IL-10 may serve as an important regulator of LC Ag-presenting function for tumor immune responses. IL-10 appears to specifically prevent the GM-CSF- induced maturation of LC Ag-presenting function when treatment with IL- 10 occurs before exposure to GM-CSF but does not reverse the established mature state.
This article has been cited by other articles:
|
|
 |
|
  R. Mittal and N. V. Prasadarao Outer Membrane Protein A Expression in Escherichia coli K1 Is Required to Prevent the Maturation of Myeloid Dendritic Cells and the Induction of IL-10 and TGF-{beta} J. Immunol., August 15, 2008; 181(4): 2672 - 2682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gray, J. T. Mao, E. Szabo, M. Kelley, J. Kurie, and G. Bepler Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 56S - 68S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Meeran, S. Katiyar, C. A. Elmets, and S. K. Katiyar Silymarin inhibits UV radiation-induced immunosuppression through augmentation of interleukin-12 in mice. Mol. Cancer Ther., July 1, 2006; 5(7): 1660 - 1668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Sharma and S. K. Katiyar Dietary grape-seed proanthocyanidin inhibition of ultraviolet B-induced immune suppression is associated with induction of IL-12 Carcinogenesis, January 1, 2006; 27(1): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lu, J.-C. Soria, X. Tang, X.-C. Xu, L. Wang, L. Mao, R. Lotan, B. Kemp, B. N. Bekele, L. Feng, et al. Prognostic Factors in Resected Stage I Non-Small-Cell Lung Cancer: A Multivariate Analysis of Six Molecular Markers J. Clin. Oncol., November 15, 2004; 22(22): 4575 - 4583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Appel, A. M. Boehmler, F. Grunebach, M. R. Muller, A. Rupf, M. M. Weck, U. Hartmann, V. L. Reichardt, L. Kanz, T. H. Brummendorf, et al. Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells Blood, January 15, 2004; 103(2): 538 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Mao, M. D. Roth, K. J. Serio, F. Baratelli, L. Zhu, E. C. Holmes, R. M. Strieter, and S. M. Dubinett Celecoxib Modulates the Capacity for Prostaglandin E2 and Interleukin-10 Production in Alveolar Macrophages from Active Smokers Clin. Cancer Res., December 1, 2003; 9(16): 5835 - 5841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Soria, C. Moon, B. L. Kemp, D. D. Liu, L. Feng, X. Tang, Y.-S. Chang, L. Mao, and F. R. Khuri Lack of Interleukin-10 Expression Could Predict Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer Clin. Cancer Res., May 1, 2003; 9(5): 1785 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Beissert, D. Ruhlemann, T. Mohammad, S. Grabbe, A. El-Ghorr, M. Norval, H. Morrison, R. D. Granstein, and T. Schwarz IL-12 Prevents the Inhibitory Effects of cis-Urocanic Acid on Tumor Antigen Presentation by Langerhans Cells: Implications for Photocarcinogenesis J. Immunol., December 1, 2001; 167(11): 6232 - 6238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-C. Sheu, R.-H. Lin, H.-C. Lien, H.-N. Ho, S.-M. Hsu, and S.-C. Huang Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer J. Immunol., September 1, 2001; 167(5): 2972 - 2978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Nelson, S. Mukherjee, C. Bundell, S. Fisher, D. van Hagen, and B. Robinson Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective "Arming" of Tumor Antigen-Specific CTL J. Immunol., May 1, 2001; 166(9): 5557 - 5566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Qin, Y. Ding, H. Tahara, and J. S. Bromberg Viral IL-10-Induced Immunosuppression Requires Th2 Cytokines and Impairs APC Function Within the Allograft J. Immunol., February 15, 2001; 166(4): 2385 - 2393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cervenak, L. Morbidelli, D. Donati, S. Donnini, T. Kambayashi, J. L. Wilson, H. Axelson, E. Castanos-Velez, H.-G. Ljunggren, R. D. W. Malefyt, et al. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10 Blood, October 1, 2000; 96(7): 2568 - 2573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fortsch, M. Rollinghoff, and S. Stenger IL-10 Converts Human Dendritic Cells into Macrophage-Like Cells with Increased Antibacterial Activity Against Virulent Mycobacterium tuberculosis J. Immunol., July 15, 2000; 165(2): 978 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Visonneau, A. Cesano, D. L. Porter, S. L. Luger, L. Schuchter, M. Kamoun, M. H. Torosian, K. Duffy, C. Sickles, E. A. Stadtmauer, et al. Phase I Trial of TALL-104 Cells in Patients with Refractory Metastatic Breast Cancer Clin. Cancer Res., May 1, 2000; 6(5): 1744 - 1754. [Abstract] [Full Text]
|
|
|
|
|
|
B. Almand, J. R. Resser, B. Lindman, S. Nadaf, J. I. Clark, E. D. Kwon, D. P. Carbone, and D. I. Gabrilovich Clinical Significance of Defective Dendritic Cell Differentiation in Cancer Clin. Cancer Res., May 1, 2000; 6(5): 1755 - 1766. [Abstract] [Full Text]
|
|
|
|
|
|
M. Stolina, S. Sharma, Y. Lin, M. Dohadwala, B. Gardner, J. Luo, L. Zhu, M. Kronenberg, P. W. Miller, J. Portanova, et al. Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis J. Immunol., January 1, 2000; 164(1): 361 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Steinbrink, H. Jonuleit, G. Muller, G. Schuler, J. Knop, and A. H. Enk Interleukin-10-Treated Human Dendritic Cells Induce a Melanoma-Antigen-Specific Anergy in CD8+ T Cells Resulting in a Failure to Lyse Tumor Cells Blood, March 1, 1999; 93(5): 1634 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Halak, H. C. Maguire Jr., and E. C. Lattime Tumor-induced Interleukin-10 Inhibits Type 1 Immune Responses Directed at a Tumor Antigen As Well As a Non-Tumor Antigen Present at the Tumor Site Cancer Res., February 1, 1999; 59(4): 911 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Menetrier-Caux, G. Montmain, M.C. Dieu, C. Bain, M.C. Favrot, C. Caux, and J.Y. Blay Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor Blood, December 15, 1998; 92(12): 4778 - 4791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ishida, T. Oyama, D. P. Carbone, and D. I. Gabrilovich Defective Function of Langerhans Cells in Tumor-Bearing Animals Is the Result of Defective Maturation from Hemopoietic Progenitors J. Immunol., November 1, 1998; 161(9): 4842 - 4851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Holan, L. Kuffova, A. Zajicova, M. Krulova, M. Filipec, P. Holler, and A. Jancarek Urocanic Acid Enhances IL-10 Production in Activated CD4+ T Cells J. Immunol., October 1, 1998; 161(7): 3237 - 3241. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
